FeesSafety
Pluang+

BBOT reports strong Q3 2026 results with promising cancer drug data and cash runway into 2029

Company Fundamentals
10 Nov 2026, 23:15 WIB
GlobeNewsWire
View Source
Bullish
BBOT reports strong Q3 2026 results with promising cancer drug data and cash runway into 2029

BridgeBio Oncology Therapeutics (BBOT) reported Q3 2026 financial results highlighting promising clinical data for its KRAS-targeting cancer drugs, including a 75% response rate for BBO-8520 combined with pembrolizumab in lung cancer patients. The company is advancing multiple drug combinations targeting KRAS-mutant cancers and expects further data updates in late 2026. With $315 million in cash, BBOT has a runway to fund operations through 2029, positioning it well for continued development of its oncology pipeline.

BridgeBio Oncology Therapeutics' Q3 2026 results provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 11, 2026 04:02 WIB: out of 150 priced health-sector US stocks, 52 rose and 97 fell. Notably, ACAD (ACADIA Pharmaceuticals Inc.) gained 11.24% with 71% buy orders and a typical hold time of 77 days, contrasting with WGS (GeneDx Holdings Corp) which dropped 16.63% despite 100% buy orders and a 21-day hold time, and IONS (Ionis Pharmaceuticals Inc.) which fell 9.35% with a near-even buy/sell split and a 4-day hold time.

More News

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...

Company Fundamentals
Bullish
3 hours ago
Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
3 hours ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
3 hours ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
5 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App